About Us

SciencewerkeDX, a division of Sciencewerke Pte Ltd, works with market leading innovative diagnostic companies across multiple medical specialties to provide doctors, patients and their families with proprietary actionable genetic and molecular diagnostic tests that will allow for better medical management and treatment decisions, leading to a better quality of life.

SciencewerkeDX — Better tests. Better care. Better lives.

Sciencewerke Pte Ltd is a sales, marketing and distribution company focused on cutting-edge and emerging technologies in biomedical and life sciences. Founded in 2005, Sciencewerke is headquartered in Singapore and has offices in Malaysia and Indonesia. Over the years, we have established ourselves to become a niche provider of market-leading Genomics, Proteomics, Cellomics, Bio-imaging and Molecular Diagnostics solutions. www.sciencewerke.com.

Our Partners

Myriad Genetics, Inc.
Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patients’ lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad’s molecular diagnostic tests are based on an understanding of the role genes play in human disease and were developed with a commitment to improving an individual’s decision making process for monitoring and treating disease. Myriad is focused on strategic directives to introduce new products, including companion diagnostics, as well as expanding internationally. www.myriad.com.


CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families. CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics. CENTOGENE is committed to un-rare rare diseases by using their worldwide knowledge in the rare disease market, understanding the epidemiology, analyzing clinical heterogeneity of the more than 3800 diseases and developing innovative biomarkers. Based on this knowledge they are bringing rationality to treatment decisions and, thereby, accelerate the development of new orphan drugs. https://www.centogene.com/

Genomind, Inc.

Genomind is a leading mental health care company, delivering the genetic testing tools designed to empower clinicians to make better informed treatment decisions and create better outcomes for patients with mental illnesses. As the scientific leader in genetic testing, Genomind’s flagship offering is Genomind Professional PGx Express (formerly Genecept Assay)– the most comprehensive mental health genetic service available. Supported by a world-class genetics lab and unique consultative approach, Genomind is advancing a new paradigm of personalized medicine in mental health care. www.genomind.com